DH News and Press, Definitive Healthcare Corp. From 02/28/24

Fourth quarter revenue grew 9% year-over-year to $65.9 million Full year 2023 revenue grew 13% year-over-year to $251.4 million FRAMINGHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (...

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

FRAMINGHAM, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended Decembe...

2024-01-29 01:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-18 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-17 14:45:02 ET William Blair analyst issues OUTPERFORM recommendation for DH on January 17, 2024 03:19PM ET. The previous analyst recommendation was Outperform. DH was trading at $8.75 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-01-16 16:18:40 ET More on Definitive Healthcare Definitive Healthcare: Undervalued Vs. Peers Given Revenue Growth And Margin Expansion Definitive Healthcare Corp. 2023 Q3 - Results - Earnings Call Presentation Definitive Healthcare Corp. (DH) Q3 2023 Earnings Ca...

Jason Krantz, Founder and Executive Chairman, to Serve as Interim CEO Company Reaffirms Fourth Quarter 2023 Guidance and Issues Preliminary Guidance for 2024 FRAMINGHAM, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH) (the “Company”),...

2024-01-11 08:30:00 ET Summary GoodRx Holdings announced preliminary financial results for Q4 2023, exceeding guidance on the top line. The company's financial performance in previous quarters has been disappointing, with declining revenue and profitability metrics. Management...

2024-01-05 04:29:24 ET More on Definitive Healthcare Definitive Healthcare: Undervalued Vs. Peers Given Revenue Growth And Margin Expansion Seeking Alpha’s Quant Rating on Definitive Healthcare Historical earnings data for Definitive Healthcare For fur...